Clorox (NYSE:CLX) Price Target Lowered to $155.00 at Citigroup

Clorox (NYSE:CLX) had its price objective decreased by research analysts at Citigroup from $165.00 to $155.00 in a research report issued on Tuesday, Benzinga reports. The brokerage currently has a “neutral” rating on the stock. Citigroup’s price objective indicates a potential upside of 8.93% from the stock’s previous close.

Several other brokerages have also issued reports on CLX. DA Davidson restated a “neutral” rating and set a $162.00 price target on shares of Clorox in a research note on Monday, February 5th. Morgan Stanley restated an “equal weight” rating and set a $160.00 price target on shares of Clorox in a research note on Tuesday, March 26th. Barclays decreased their price objective on Clorox from $148.00 to $136.00 and set an “underweight” rating on the stock in a report on Wednesday, April 10th. UBS Group lifted their price objective on Clorox from $145.00 to $170.00 and gave the company a “neutral” rating in a report on Friday, February 2nd. Finally, JPMorgan Chase & Co. lifted their price objective on Clorox from $145.00 to $152.00 and gave the company a “neutral” rating in a report on Thursday, January 18th. Four analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the stock. Based on data from MarketBeat, Clorox presently has a consensus rating of “Hold” and a consensus target price of $148.63.

Clorox Trading Down 0.1 %

Clorox stock opened at $142.29 on Tuesday. Clorox has a 52 week low of $114.68 and a 52 week high of $178.21. The company has a debt-to-equity ratio of 11.37, a quick ratio of 0.57 and a current ratio of 0.89. The firm has a market capitalization of $17.66 billion, a PE ratio of 225.86, a PEG ratio of 2.19 and a beta of 0.43. The business’s 50-day simple moving average is $150.40 and its 200-day simple moving average is $141.69.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, February 1st. The company reported $2.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.08 by $1.08. Clorox had a return on equity of 319.41% and a net margin of 1.09%. The firm had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.80 billion. During the same period in the previous year, the company posted $0.98 earnings per share. The company’s quarterly revenue was up 16.0% compared to the same quarter last year. Equities research analysts forecast that Clorox will post 5.52 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the stock. Coston McIsaac & Partners raised its position in Clorox by 2.5% in the 1st quarter. Coston McIsaac & Partners now owns 32,702 shares of the company’s stock worth $5,006,000 after purchasing an additional 805 shares during the last quarter. Baker Ellis Asset Management LLC bought a new position in Clorox in the 1st quarter worth approximately $214,000. Toth Financial Advisory Corp raised its position in Clorox by 15.3% in the 1st quarter. Toth Financial Advisory Corp now owns 10,169 shares of the company’s stock worth $1,557,000 after purchasing an additional 1,351 shares during the last quarter. ERn Financial LLC bought a new position in Clorox in the 1st quarter worth approximately $210,000. Finally, Exeter Financial LLC raised its position in Clorox by 16.5% in the 1st quarter. Exeter Financial LLC now owns 10,073 shares of the company’s stock worth $1,476,000 after purchasing an additional 1,425 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.